Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia
- 8 November 2004
- journal article
- other
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 35 (2) , 207-208
- https://doi.org/10.1038/sj.bmt.1704742
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiencyBlood, 2004
- Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphomaBlood, 2004
- Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrowBone Marrow Transplantation, 1997
- Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 1997